Author

David Wood

The University of QueenslandORCID 0000-0002-1001-2019Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

David Wood2 papers · Harvard University

Biology Disciplines

Click to filter author papers

Microbiology· 2 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:metagenomics· 3 Approach:experimental assay· 2 Organism:human· 2 Assay:metabolomics· 2 Research Focus:database / resource· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Philip HugenholtziD· 3 shared Kate L. BowermaniD· 2 shared Lutz KrauseiD· 2 shared Simon KeelyiD· 2 shared A. F. FaiziD· 1 shared Alena L. PribyliD· 1 shared Andrea Rabellino· 1 shared Annalicia VaughaniD· 1 shared

Activity by Year

2024-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

Philip HugenholtzORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologyMicrobial GenomicsPeer-reviewedJan 9, 2026

A molecular inventory of the faecal microbiomes of 23 marsupial species

Kate L Bowerman, Rochelle M. Soo, Pierre-Alain Chaumeil…·Philip Hugenholtz

This paper presents a comprehensive analysis of the faecal microbiomes of 23 marsupial species, revealing novel microbial genomes and highlighting the influence of host phylogeny on microbiome composition.

DOI 10.1099/mgen.0.001601

multiple speciesmetagenomics

𝕏 PostBluesky

MicrobiologybioRxivPreprintOct 22, 2024

A rational approach for the targeted discovery and characterisation of microbiome-derived therapeutics

Lutz Krause, Joel A. Boyd, Charlotte Vivian…·Páraic Ó Cuív

This paper identifies microbiome-derived therapeutics for IBD using a metagenome-guided approach, showing improved disease markers and safety in preclinical models.

2 citations

humanmetagenomics

𝕏 PostBluesky

PhysiologyGutPeer-reviewedFeb 8, 2024

Fecal microbial transfer and complex carbohydrates mediate protection against COPD

Kurtis F. Budden, Shakti Dhar Shukla, Kate L. Bowerman…·Philip M. Hansbro

This study shows that fecal microbial transfer and complex carbohydrates can reduce COPD symptoms in mice and humans, linking gut microbiota to disease progression.

78 citationstop 1%

𝕏 PostBluesky